Rockwell Medical (RMTI) Total Liabilities (2010 - 2026)
Rockwell Medical (RMTI) posted Total Liabilities of $21.6 million for Q1 2026, up 6.95% on a QoQ basis from $20.2 million in Q4 2025, and down 3.89% year-over-year from $22.4 million in Q1 2025.
Rockwell Medical (RMTI) Total Liabilities (2010 - 2026) Analysis & Trends
Rockwell Medical's Total Liabilities history runs 17 years deep, the most recent figure standing at $21.6 million for Q1 2026.
- Quarterly Total Liabilities fell 3.89% year-over-year to $21.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.6 million (down 3.89% YoY) and the FY2025 annual result came in at $20.2 million, down 24.26% from the prior year.
- Total Liabilities was $21.6 million for Q1 2026 at Rockwell Medical, up from $20.2 million in the prior quarter.
- Across five years, Total Liabilities topped out at $42.2 million in Q1 2022 and bottomed at $20.2 million in Q4 2025.
- A 5-year average of $28.9 million and a median of $28.5 million in 2023 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2023 — Total Liabilities sank 33.88% — and 2024, when it climbed 7.7%.
- Rockwell Medical's Total Liabilities stood at $32.5 million in 2022, then slipped by 5.06% to $30.9 million in 2023, then slipped by 13.79% to $26.6 million in 2024, then retreated by 24.26% to $20.2 million in 2025, then climbed by 6.95% to $21.6 million in 2026.
- Business Quant data shows RMTI's Total Liabilities at $21.6 million in Q1 2026, $20.2 million in Q4 2025, and $20.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | 21.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.57 Mn |
| Dec 31, 2025 | 20.16 Mn |
| Sep 30, 2025 | 20.47 Mn |
| Jun 30, 2025 | 22.22 Mn |
| Mar 31, 2025 | 22.44 Mn |
| Dec 31, 2024 | 26.62 Mn |
| Sep 30, 2024 | 27.95 Mn |
| Jun 30, 2024 | 29.53 Mn |
| Mar 31, 2024 | 30.08 Mn |
| Dec 31, 2023 | 30.88 Mn |
| Sep 30, 2023 | 31.09 Mn |
| Jun 30, 2023 | 28.51 Mn |
| Mar 31, 2023 | 27.93 Mn |
| Dec 31, 2022 | 32.53 Mn |
| Sep 30, 2022 | 38.05 Mn |
| Jun 30, 2022 | 38.97 Mn |
| Mar 31, 2022 | 42.24 Mn |
| Dec 31, 2021 | 46.04 Mn |
| Sep 30, 2021 | 47.61 Mn |
| Jun 30, 2021 | 45.48 Mn |